In vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glycerides
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in Pharmaceutica Acta Helvetiae
- Vol. 70 (4) , 307-313
- https://doi.org/10.1016/0031-6865(95)00036-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The gastrointestinal transit of a controlled release formulation of indomethacinInternational Journal of Pharmaceutics, 1990
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Definition of mean residence times in pharmacokineticsBiopharmaceutics & Drug Disposition, 1987
- THe Incorporation and in Vitro Release Profiles of Liquid, Deliquescent or Unstable Drugs with Fusible Excipients in Hard Gelatin CapsulesDrug Development and Industrial Pharmacy, 1986
- Comparative multiple dose kinetics of two formulations of indomethacinEuropean Journal of Clinical Pharmacology, 1983
- A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.British Journal of Clinical Pharmacology, 1982
- Comparison of the in vitro dissolution behaviour of various indomethacin formulations with their in vivo bioavailabilityJournal of Pharmacy and Pharmacology, 1981
- Indomethacin serum concentrations in man. Effects of dosage, food, and antacid.Annals of the Rheumatic Diseases, 1976
- Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in manJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Pharmacokinetics of indomethacinClinical Pharmacology & Therapeutics, 1975